Inventor · disambiguated record
Ching Wah Chong
Also filed as: CHONG CHING W · CHONG CHING WAH
8 granted patents·10 pending applications·132 citations·filing 2013–2023
88Inventor score
Top patents by PatentIndex Score
18 records- 0195US10010507B1Pharmaceutical formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Jul 3, 2018·23 cites·28 claims
- 0295US9655857B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted May 23, 2017·32 cites·37 claims
- 0394US10828259B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Nov 10, 2020·5 cites·25 claims
- 0494US10213386B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Feb 26, 2019·18 cites·23 claims
- 0592US9545407B2Formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2015·Granted Jan 17, 2017·51 cites·6 claims
- 0685US10716760B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofXENOPORT INC·Filed 2016·Granted Jul 21, 2020·2 cites·18 claims
- 0782US10940117B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Mar 9, 2021·1 cites·12 claims
- 0878US2022331252A1Pharmaceutical formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 0971US2024197661A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1070US2021145755A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1167US2019117579A1Pharmaceutical formulations of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 1266US2019015340A1Pharmaceutical formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 1362US2017258729A1Pharmaceutical Formulations of a Bruton's Tyrosine Kinase InhibitorPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 1461US9597292B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofXENOPORT INC·Filed 2013·Granted Mar 21, 2017·0 cites·4 claims
- 1561US2020000758A1Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs ThereofXENOPORT INC·Filed 2019·Application pending·0 cites
- 1655US2019282578A1Novel formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 1751US2018028537A1Novel Formulations of a Bruton's Tyrosine Kinase InhibitorPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 1850US2017079981A1Novel Formulations of a Bruton's Tyrosine Kinase InhibitorPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ching Wah Chong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →